Advisory Board March 10, 2025

Sycamore Partners on Thursday announced that it has agreed to a $10 billion deal to acquire Walgreens Boots Alliance, meaning the pharmacy chain will go private after nearly 100 years as a publicly traded company.

Details on the deal

As part of the deal, Sycamore has agreed to pay $11.45 a share in cash for Walgreens, which represents an equity value of around $10 billion and 29% above where the pharmacy chain’s stock was trading last year.

Shareholders could also be paid an additional $3 per share, or around $2.7 billion, if Sycamore is successful in shedding the assets of the VillageMD primary care business.

The total value of the deal, including Walgreens’ roughly $9 billion in debt and...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
The pharmacy change 'key to your future existence as a health plan'
Healthcare & Life Sciences Private Equity Deal Tracker: Sycamore Partners to Acquire Walgreens
How Pharmacy Deserts are Being Defined, Identified
Sun Pharma buys Checkpoint and its new cancer drug
British scientists unveil world-leading technology to speed up drug discovery

Share This Article